Diaceutics Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BJQTGV64
GBP
1.37
0.08 (6.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
PureTech Health Plc
Optibiotix Health Plc
Scancell Holdings Plc
Diaceutics Plc
Ondine Biomedical, Inc.
4basebio Plc
Oxford Biomedica Plc
e-Therapeutics Plc
HemoGenyx Pharmaceuticals Plc
Oxford BioDynamics Plc
Oncimmune Holdings Plc
Why is Diaceutics Plc ?
1
Poor Management Efficiency with a low ROE of 0.95%
  • The company has been able to generate a Return on Equity (avg) of 0.95% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate -199.82% of over the last 5 years
3
The company has declared Negative results for the last 3 consecutive quarters
  • RAW MATERIAL COST(Y) Grown by 8.49% (YoY)
  • CASH AND EQV(HY) Lowest at GBP 12.74 MM
  • DEBT-EQUITY RATIO (HY) Highest at -29.31 %
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 16.31%, its profits have risen by 46.7%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Diaceutics Plc for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Diaceutics Plc
-100.0%
0.19
30.08%
FTSE 100
16.5%
1.23
12.99%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
19.07%
EBIT Growth (5y)
-199.82%
EBIT to Interest (avg)
-1.06
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.53
Tax Ratio
10.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.74%
ROE (avg)
0.95%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.76
EV to EBIT
-58.26
EV to EBITDA
45.91
EV to Capital Employed
4.79
EV to Sales
3.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.22%
ROE (Latest)
-4.08%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Diaceutics Plc
Pre-Tax Profit
At GBP 1.36 MM has Grown at 358.29%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (GBP MM)

Net Profit
At GBP 0.88 MM has Grown at 437.55%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (GBP MM)

Net Sales
Highest at GBP 19.84 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (GBP MM)

Net Sales
At GBP 19.84 MM has Grown at 44.01%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (GBP MM)

Operating Profit
Highest at GBP 3.47 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (GBP MM)

Here's what is not working for Diaceutics Plc
Cash and Eqv
Lowest at GBP 12.74 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -29.31 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 8.49% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales